Molina Healthcare (MOH) Receiving Somewhat Positive News Coverage, Report Shows

News headlines about Molina Healthcare (NYSE:MOH) have trended somewhat positive recently, according to Accern Sentiment Analysis. Accern scores the sentiment of press coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Molina Healthcare earned a media sentiment score of 0.08 on Accern’s scale. Accern also gave news stories about the company an impact score of 44.9287160066934 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

These are some of the media headlines that may have effected Accern’s analysis:

Molina Healthcare (NYSE MOH) opened at 66.62 on Friday. Molina Healthcare has a 1-year low of $42.56 and a 1-year high of $72.79. The stock’s market cap is $3.81 billion. The firm has a 50-day moving average price of $62.47 and a 200 day moving average price of $60.18.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Wednesday, August 2nd. The company reported ($0.01) EPS for the quarter, missing the consensus estimate of $0.86 by ($0.87). The business had revenue of $5 billion during the quarter, compared to analyst estimates of $4.88 billion. Molina Healthcare had a negative net margin of 1.07% and a positive return on equity of 16.10%. The firm’s quarterly revenue was up 14.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.67 earnings per share. On average, equities research analysts anticipate that Molina Healthcare will post ($2.96) EPS for the current fiscal year.

A number of analysts recently issued reports on MOH shares. Deutsche Bank AG restated a “hold” rating and issued a $72.00 price target on shares of Molina Healthcare in a research report on Wednesday, August 9th. Bank of America Corporation raised their price target on Molina Healthcare from $59.00 to $60.00 and gave the stock an “underperform” rating in a research report on Friday, July 14th. Morgan Stanley upgraded Molina Healthcare from an “underweight” rating to an “overweight” rating and lifted their target price for the stock from $65.00 to $68.00 in a research report on Thursday, August 17th. Zacks Investment Research downgraded Molina Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, July 17th. Finally, ValuEngine downgraded Molina Healthcare from a “buy” rating to a “hold” rating in a research report on Tuesday, July 11th. Four research analysts have rated the stock with a sell rating, eight have assigned a hold rating and four have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $62.39.

COPYRIGHT VIOLATION NOTICE: This story was first posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this story on another site, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark law. The legal version of this story can be viewed at https://ledgergazette.com/2017/09/17/somewhat-positive-press-coverage-somewhat-unlikely-to-affect-molina-healthcare-moh-stock-price.html.

In related news, COO Terry Bayer sold 415 shares of Molina Healthcare stock in a transaction on Monday, July 3rd. The stock was sold at an average price of $69.24, for a total transaction of $28,734.60. Following the completion of the transaction, the chief operating officer now directly owns 80,672 shares of the company’s stock, valued at $5,585,729.28. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director J Mario Md Molina sold 15,000 shares of Molina Healthcare stock in a transaction on Monday, July 3rd. The stock was sold at an average price of $68.58, for a total value of $1,028,700.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 314,323 shares of company stock valued at $20,373,701. 6.20% of the stock is currently owned by insiders.

About Molina Healthcare

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

Insider Buying and Selling by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply